IllnessCataract, syndromal; differential diagnosis
Summary
A curated panel containing 123 genes for the comprehensive analysis of practically all known genetic and syndromic cataract entities
268,1 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
ABHD12 | 1197 | NM_001042472.3 | AR | |
ADAMTS10 | 3312 | NM_030957.4 | AR | |
AGK | 1269 | NM_018238.4 | AR | |
AGPS | 1977 | NM_003659.4 | AR | |
ALDH18A1 | 2388 | NM_002860.4 | AD, AR | |
ANAPC1 | 5835 | NM_022662.4 | AR | |
ATAD3A | 1761 | NM_001170535.3 | AR | |
B3GLCT | 1497 | NM_194318.4 | AR | |
BCOR | 5166 | NM_017745.6 | XL | |
CDK9 | 1126 | NM_001261.4 | AR | |
COG4 | 2295 | NM_001195139.2 | AR | |
COL11A1 | 5421 | NM_001854.4 | AD, AR | |
COL18A1 | 4560 | NM_001379500.1 | AR | |
COL2A1 | 4464 | NM_001844.5 | AD | |
COL4A1 | 5010 | NM_001845.6 | AD, Mult | |
COL4A5 | 5058 | NM_000495.5 | XL | |
COPB1 | 2883 | NM_001144061.2 | AR | |
CRYAA | 522 | NM_000394.4 | AD, AR | |
CRYAB | 528 | NM_001885.3 | AD, AR | |
CRYBA4 | 591 | NM_001886.3 | AD | |
CRYBB1 | 759 | NM_001887.4 | AD, AR | |
CRYBB2 | 618 | NM_000496.3 | AD | |
CRYBB3 | 636 | NM_004076.5 | AD, AR | |
CRYGC | 525 | NM_020989.4 | AD | |
CTDP1 | 2529 | NM_004715.5 | AR | |
CYP27A1 | 1596 | NM_000784.4 | AR | |
CYP51A1 | 1540 | NM_000786.4 | XL | |
DHCR7 | 1428 | NM_001360.3 | AR | |
DMPK | 1920 | NM_001081563.2 | AD | |
DNMBP | 6032 | NM_015221.4 | AD | |
DYRK1A | 2292 | NM_001396.5 | AD | |
EED | 2100 | NM_003797.5 | AD | |
EIF2B2 | 1056 | NM_014239.4 | AD | |
EPG5 | 7740 | NM_020964.3 | AR | |
EPHA2 | 2931 | NM_004431.5 | AD | |
ERCC2 | 2283 | NM_000400.4 | AR | |
ERCC3 | 2349 | NM_000122.2 | AR | |
ERCC6 | 4482 | NM_000124.4 | AR | |
ERCC8 | 1191 | NM_000082.4 | AR | |
EYA1 | 1779 | NM_000503.6 | AD | |
FAR1 | 1548 | NM_032228.6 | AR, AD | |
FBN1 | 8616 | NM_000138.5 | AD | |
FOXC1 | 1662 | NM_001453.3 | AD | |
FOXE3 | 960 | NM_012186.3 | AD, AR | |
FTL | 528 | NM_000146.4 | AD | |
GALK1 | 1179 | NM_000154.2 | AR | |
GALM | 1069 | NM_138801.3 | AR | |
GALT | 1140 | NM_000155.4 | AR | |
GCNT2 | 1203 | NM_001491.3 | n.k. | |
GEMIN4 | 3177 | NM_015721.3 | AR | |
GFER | 618 | NM_005262.3 | AR | |
GLS | 1797 | NM_001256310.2 | AD | |
GNPAT | 2043 | NM_014236.4 | AR | |
GTF2H5 | 216 | NM_207118.3 | AR | |
HMX1 | 1047 | NM_018942.3 | AR | |
HTRA2 | 1377 | NM_013247.5 | AR | |
HYCC1 | 1566 | NM_032581.4 | AR | |
INPP5K | 1119 | NM_016532.4 | AR | |
INTS1 | 6843 | NM_001080453.3 | AR | |
JAM3 | 780 | NM_001205329.2 | AR | |
LCAT | 1323 | NM_000229.2 | AR | |
LIM2 | 648 | NM_030657.4 | AR | |
LONP1 | 2688 | NM_001276479.2 | AR | |
LSS | 2303 | NM_001001438.3 | AR | |
MAF | 1212 | NM_005360.5 | AD | |
MAN2B1 | 3036 | NM_000528.4 | AR | |
MED27 | 1160 | NM_001253881.2 | AR | |
MSMO1 | 489 | NM_001017369.3 | AR | |
MYH9 | 5883 | NM_002473.6 | AD | |
NACC1 | 1589 | NM_052876.4 | AD | |
NDP | 402 | NM_000266.4 | XLR | |
NF2 | 1788 | NM_000268.4 | AD | |
NHS | 4425 | NM_001136024.4 | XL | |
NUP188 | 5294 | NM_015354.3 | AD | |
OCRL | 2706 | NM_000276.4 | XLR | |
OPA3 | 540 | NM_025136.4 | AD | |
P3H2 | 1584 | NM_001134418.2 | AR | |
PAX6 | 1269 | NM_000280.5 | AD | |
PEX1 | 3852 | NM_000466.3 | AR | |
PEX10 | 1041 | NM_153818.2 | AR | |
PEX11B | 780 | NM_003846.3 | AR | |
PEX12 | 1080 | NM_000286.3 | AR | |
PEX13 | 1212 | NM_002618.4 | AR | |
PEX14 | 1134 | NM_004565.3 | AR | |
PEX16 | 1011 | NM_004813.4 | AR | |
PEX19 | 900 | NM_002857.4 | AR | |
PEX2 | 918 | NM_000318.3 | AR | |
PEX26 | 918 | NM_017929.6 | AR | |
PEX3 | 1122 | NM_003630.3 | AR | |
PEX5 | 1920 | NM_001131025.2 | AR | |
PEX6 | 2943 | NM_000287.4 | AR | |
PEX7 | 972 | NM_000288.4 | AR | |
PGRMC1 | 588 | NM_006667.5 | AD | |
PIK3C2A | 5093 | NM_002645.4 | AR | |
PITX3 | 909 | NM_005029.4 | AD | |
PLOD3 | 2217 | NM_001084.5 | AR | |
POLG | 3720 | NM_002693.3 | AD, AR | |
POMT1 | 2244 | NM_007171.4 | AR | |
PSMC3 | 1501 | NM_002804.5 | AD | |
PXDN | 4440 | NM_012293.3 | AR | |
RAB18 | 621 | NM_021252.5 | AR | |
RAB3GAP1 | 2946 | NM_012233.3 | AR | |
RAB3GAP2 | 4182 | NM_012414.4 | AR | |
RECQL4 | 3628 | NM_004260.4 | AR | |
RIC1 | 3498 | NM_001135920.4 | AD | |
SEC23A | 2298 | NM_006364.4 | AR | |
SIL1 | 1386 | NM_022464.5 | AR | |
SLC16A12 | 1551 | NM_213606.4 | AD | |
SLC2A1 | 1479 |
| NM_006516.4 | AD |
SLC33A1 | 1650 | NM_004733.4 | AR | |
SMG8 | 2988 | NM_018149.7 | AR | |
SRD5A3 | 957 | NM_024592.5 | AR | |
SREBF1 | 3534 | NM_001005291.3 | AD, AR | |
TBC1D20 | 1212 | NM_144628.4 | AR | |
TKFC | 2102 | NM_015533.4 | AR | |
VPS4A | 1325 | NM_013245.3 | AD | |
VSX2 | 1086 | NM_182894.3 | AR | |
WFS1 | 2673 | NM_006005.3 | AD, AR | |
WRN | 4299 | NM_000553.6 | AR | |
XYLT2 | 2598 | NM_022167.4 | AR | |
ZNF526 | 2013 | NM_133444.3 | AR |
Informations about the disease
Heterogenous disorders
- Alias: Cataract, syndromal
- Allelic: Adult i phenotype without cataract (GCNT2)
- Allelic: Blood group, Ii (GCNT2)
- Allelic: Cardiomyopathy, dilated, 1II (CRYAB)
- Allelic: Cataract 38, AR (AGK)
- Allelic: Deafness, autosomal dominant 37 (COL11A1)
- Allelic: Dent disease 2 (OCRL)
- Allelic: Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
- Allelic: Fibrochondrogenesis 1 (COL11A1)
- Allelic: Lumbar disc herniation, susceptibility to (COL11A1)
- Allelic: Myopathy, myofibrillar, 2 (CRYAB)
- Allelic: Premature ovarian insufficiency [panelapp] (PGRMC1)
- Allelic: Spastic paraplegia 9A, AD (ALDH18A1)
- Allelic: Spastic paraplegia 9B, AR (ALDH18A1)
- Allelic: Stickler sydrome, type I, nonsyndromic ocular (COL2A1)
- Allelic: Stickler syndrome, type II (COL11A1)
- Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
- Allelic: Vitreoretinopathy with phalangeal epiphyseal dysplasia (COL2A1)
- Allelic: Xeroderma pigmentosum, group D (ERCC2)
- Lysyl hydroxylase 3 deficiency (PLOD3)
- 3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement, neutropenia (CLPB)
- 3-methylglutaconic aciduria, type VIII (HTRA2)
- AR cataract due to abnormal sterol metabolism [panelapp] (CYP51A1)
- Acromicric dysplasia (FBN1)
- Allelic: Pontocereb. hypoplasia, hypotonia, respiratory insufficiency s., neonatal lethal (ATAD3)
- Alopecia-mental retardation syndrome 4 (LSS)
- Alport syndrome 1, XL (COL4A5)
- Alport syndrome 1, XL (COL4A5)
- Alzahrani-Kuwahara syndrome: global developmental delay ID, poor/absent speech (SMG8)
- Anterior segment anomalies with/-out cataract (EYA1)
- Anterior segment dysgenesis 1, multiple subtypes (PITX)
- Anterior segment dysgenesis 2, multiple subtypes (FOXE3)
- Anterior segment dysgenesis 3, multiple subtypes (FOXC1)
- Anterior segment dysgenesis 5, multiple subtypes (PAX6)
- Anterior segment dysgenesis 7, with sclerocornea (PXDN)
- Axenfeld-Rieger syndrome, type 3 (FOXC1)
- Ayme-Gripp syndrome (MAF)
- Baralle-Macken syndrome: neurodevelopmental disorder, cataracts, var. microcephaly (COPB1)
- Brain small vessel disease with/-out ocular anomalies (COL4A1)
- Branchiooculofacial syndrome (TFAP2A)
- Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
- CATIFA syndrome: cleft lip, cataract, tooth abnormality, ID, face dysmorph, ADHS (RIC1)
- CIMDAG syndr.: cereb. hypoplasia, cataract, ID, microceph., dystonia, anemia, red. growth (VPS4A)
- CODAS [cerebral, ocular, dental, auricular + skeletal anomalies] syndrome (LONP1)
- Cataract 1, multiple types (GJA8)
- Cataract 11, multiple types (PITX)
- Cataract 11, syndromic, AR (PITX)
- Cataract 13 with adult i phenotype (GCNT2)
- Cataract 14, multiple types (GJA3)
- Cataract 15, multiple types (MIP)
- Cataract 16, multiple types (CRYAB)
- Cataract 17, multiple types (CRYBB1)
- Cataract 19 (LIM2)
- Cataract 2, multiple types (CRYGC)
- Cataract 21, multiple types (MAF)
- Cataract 22 (CRYBB3)
- Cataract 23 (CRYBA4)
- Cataract 3, multiple types (CRYBB2)
- Cataract 34, multiple types (FOXE3)
- Cataract 40, X-linked (NHS)
- Cataract 41 (WFS1)
- Cataract 44 (LSS)
- Cataract 47, juvenile, with microcornea (SLC16A12)
- Cataract 48 (DNMBP1)
- Cataract 6, multiple types (EPHA2)
- Cataract 9, multiple types (CRYAA)
- Cataract with late-onset corneal dystrophy (PAX6)
- Cerebrooculofacioskeletal syndrome 2 (ERCC2)
- Cerebrotendinous xanthomatosis (CYP27A1)
- Cohen-Gibson syndrome (EED)
- Congenital cataracts, facial dysmorphism, neuropathy (CTDP1)
- Congenital cataracts, hearing loss + neurodegeneration (SLC33A1)
- Congenital disorder of glycosylation, type IIj (COG4)
- Craniolenticulosutural dysplasia (SEC23A)
- Cutis laxa, AD (ALDH18A1)
- Cutis laxa, AR, type IIIA (ALDH18A1)
- Dentici-Novelli neurodevelopmental syndrome (ZNF526)
- Developmental + epileptic encephalopathy 71 (GLS
- Dystonia 9 (SLC2A1)
- Ectopia lentis, familial (FBN1)
- Exudative vitreoretinopathy 2, XL (NDP)
- Fish-eye disease (LCAT)
- GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
- GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
- Galactokinase deficiency with cataracts (GALK1)
- Galactosemia (GALT)
- Galactosemia IV (GALM)
- Geleophysic dysplasia 2 (FBN1)
- Glaucoma, primary closed-angle (COL18A1)
- Global developmental delay, progressive ataxia + elevated glutamine (GLS)
- Harel-Yoon syndrome (ATAD3)
- Hemorrhagic destruction of the brain, subependymal calcification, and cataracts (JAM3)
- Hyperferritinemia-cataract syndrome (FTL)
- Hypotrichosis 14 (LSS)
- ID, cataract; iris, ear, heart, skeletal + choanal morph., AKUT, seizures [panelapp] (CDK9)
- Ichthyosis, follicular, with atrichia + photophobia syndrome 2 (SREBF1)
- Infantile cataract, skin abnormalities, glutamate excess, impaired intellectual development (GLS)
- Intellectual developmental disorder, AD 7 (DYRK1A)
- Isolated paediatric cataract; Cataract [MONDO:0005129] [panelapp] (PGRMC1)
- Kahrizi syndrome: mental retardation, cataracts, coloboma, kyphosis, coarse face (SRD5A3)
- Knobloch syndrome, type 1 (COL18A1)
- Lathosterolosis (SC5D)
- Leukodystrophy, hypomyelinating, 5 (FAM126A)
- Leukoencephalopathy with vanishing white matter (EIF2B2)
- Lowe syndrome (OCRL)
- MASS syndrome (FBN1)
- Macrothrombocytopenia, granulocyte inclusions with/-out nephritis, sensorineural hearing loss (MYH9)
- Mannosidosis, alpha-, types I, II (MAN2B1)
- Marfan lipodystrophy syndrome (FBN1)
- Marfan syndrome (FBN1)
- Marinesco-Sjogren syndrome (SIL1)
- Marshall syndrome (COL11A1)
- Martsolf syndrome (RAB3GAP2)
- Microcephaly, congenital cataract, psoriasiform dermatitis (MSMO1)
- Microphthalmia with coloboma 3 (VSX2)
- Microphthalmia, syndromic 2 (BCOR)
- Mitochondrial DNA depletion syndrome 4B, Alpers + MNGIE types (POLG)
- Mitochondrial recessive ataxia syndrome, includes SANDO + SCAE (POLG)
- Mucoepithelial dysplasia, hereditary (SREBF1)
- Muscular dystrophy, congenital, cataracts + intellectual disability (INPP5K)
- Muscular dystrophy-dystroglycanopathy, cong. with ID, type B, 1 (POMT1)
- Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 1 (POMT1)
- Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 1 (POMT1)
- Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 1 (POMT1)
- Myopathy, mitochondrial progressive, congenital cataract, developmental delay (GFER)
- Myopia, high, cataract + vitreoretinal degeneration (P3H2)
- Myotonic dystrophy 1 (DMPK)
- Nance-Horan syndrome: cong. cataract, dental anomalies, dysmorphic features, in some cases ID (NHS)
- Neurodevelopmental disorder with cataracts, poor growth, dysmorphic facies (INTS1)
- Neurodevelopmental disorder with microcephaly, cataracts + renal abnormalities (GEMIN4)
- Neurodevelopmental disorder with spasticity, cataracts, cerebellar hypoplasia (MED27)
- Neurodevelopmental disorder, epilepsy, cataracts, feeding diff., delayed brain myelin. (NACC1)
- Neurofibromatosis, type 2 (NF2)
- Norrie disease (NDP)
- Norum disease (LCAT)
- Oculoauricular syndrome (HMX1)
- Oculoskeletodental syndrome (PIK3C2A)
- Optic atrophy 3 with cataract (OPA3)
- Ovarioleukodystrophy (EIF2B2)
- Peroxisomal fatty acyl-CoA reductase 1 disorder (FAR1)
- Peroxisome biogenesis disorders (PEX...)
- Peters-plus syndrome (B3GLCT)
- Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (ABHD12)
- Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataract (ADAMTS10)
- Progressive external ophthalmoplegia, AD 1 (POLG)
- Progressive external ophthalmoplegia, AR 1 (POLG)
- Rhizomelic chondrodysplasia punctata, type 2 (GNPAT)
- Rhizomelic chondrodysplasia punctata, type 3 (AGPS)
- Rothmund-Thomson syndrome, type 1 (ANAPC1)
- Rothmund-Thomson syndrome, type 2 (RECQL4)
- Sandestig-Stefanova s.: micro-, trigonoceph., cataract, microphth., face, camptodactyly... (NUP188)
- Saul-Wilson syndrome (COG4)
- Sengers syndrome (AGK)
- Smith-Lemli-Opitz syndrome (DHCR7)
- Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORD)
- Spondyloocular syndrome (XYLT2)
- Stickler syndrome, type I (COL2A1)
- Stiff skin syndrome (FBN1)
- Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
- Trichothiodystrophy 3, photosensitive (GTF2H5)
- Triokinase + FMN cyclase deficiency syndrome (TKFC)
- Vici syndrome (EPG5)
- Warburg micro syndrome 1 (RAB3GAP1)
- Warburg micro syndrome 2 (RAB3GAP2)
- Warburg micro syndrome 3 (RAB18)
- Warburg micro syndrome 4 (TBC1D20)
- Weill-Marchesani syndrome 2, AD (FBN1)
- Weill-Marchesani syndrome 2, dominant (FBN1)
- Werner syndrome (WRN)
- AD
- AR
- Mult
- XL
- XLR
- n.k.
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.